No results found for “”
No results found for filter “”
-
Blog articles 24.01.20
Everyday counts: 9 reasons why patients wait longer to get access to new cancer medicines
Working together to jointly identify factors which cause access delays, and co-create solutions that could accelerate time to patient access
Read Article -
Statements & press releases 22.01.20
EFPIA statement on CJEU ruling on clinical trial transparency
EFPIA notes the decision by the Court of Justice of the European Union (CJEU) in the case of PTC Therapeutics International v EMA (C-175/18 P) and MSD...
Read Article -
Blog articles 15.01.20
Cancer care in Europe: Where are we in 2020?
Creating more moments that matter: Cancer death rates are falling thanks to advances in prevention, diagnosis and treatment
Read Article -
Blog articles 15.01.20
Medicines shortages – from assumptions to evidence to action
Addressing the issue of shortages is a priority for the research-based industry in Europe as well as for supply chain stakeholders and national competent...
Read Article -
Blog articles 18.12.19
A European Cancer Plan – For better, more equal access to cancer care (Guest blog)
In a joint effort, ECCO, ECPC and EFPIA have recently put the European Cancer Plan on the agenda of a session of the European Health Forum Gastein.
Read Article -
Blog articles 12.12.19
Precision oncology: The right treatment to the right patient at the right time (Guest blog)
A new position paper highlights the value of personalised oncology treatments and biomarkers – and proposes concrete steps to accelerate their introduction....
Read Article -
Statements & press releases 06.12.19
Medicines shortages: root causes and potential solutions
Our associations are committed to stepping up efforts to prevent and to mitigate medicines shortages
Read Article -
Blog articles 04.12.19
Everyday counts: time to patient access to innovative oncology therapies in Europe
What factors delay access to new cancer medicines across Europe? Which best practices and what recommendations can improve time to patient access?
Read Article -
Statements & press releases 03.12.19
New IMI project “COMBINE” launched to accelerate the fight against antimicrobial resistance
COMBINE will support the coordination of the Innovative Medicines Initiative (IMI) Antimicrobial Resistance (AMR) Accelerator Programme to progress a pipeline...
Read Article -
Statements & press releases 29.11.19
Commission Proposal for a European Regulation on HTA
Europe cannot afford an inefficient system for joint clinical assessments
Read Article -
Blog articles 27.11.19
A European Health Data Space – a small step or a giant leap?
Voltaire once supposedly said of the Holy Roman Empire that it was neither especially Holy or Roman, nor an Empire.
Read Article -
Statements & press releases 26.11.19
European industries unite to call for an ambitious EU industrial strategy
Industry4Europe, a coalition of 149 sector Associations representing the diversity of the EU’s industrial base, today published its new Joint Paper ‘A...
Read Article
No results found for “”
No results found for filter “”
-
EFPIA News 26.09.19
A European Cancer Plan: Make it disruptive!
Cancer patient outcomes vary widely across Europe – the European Health Forum Gastein will explore how to bring the best care to all
Read Article -
EFPIA News 11.09.19
Mission Letter from EU President-elect Ursula von der Leyen to Stella Kyriakides, Commissioner-designate...
We look forward to working with Commissioner Kyriakides and her team, as well as colleagues in Member States to ensure access and availability of new treatments...
Read Article -
EFPIA News 25.07.19
Unleashing the potential of data to improve cancer care
Report from the Oncology Data Summit
Read Article -
EFPIA News 25.07.19
A busy year, before a hectic autumn
Our Oncology Platform has tackled several topics from big data and AI to drug pricing and improving patient outcomes.
Read Article -
EFPIA News 06.02.19
Open Letter from EFPIA President Dr Stefan Oschmann on the SPC manufacturing waiver
For our sector, it is essential that Europe's world-class protection of intellectual property rights be guaranteed in future. We are deeply concerned that...
Read Article -
EFPIA News 26.09.18
The Value of Health: Improving Outcomes
More effective, patient-centred, and sustainable health systems: the benefits of health outcomes measurement
Read Article -
EFPIA News 07.08.18
Exploring the science and innovation behind #WeWontRest
A new partnership with ITN Productions
Read Article -
EFPIA News 26.06.18
Video and report of the Unlocking Tomorrow’s Cures Exhibition, 22-25 May 2018, European Parliament
The exhibition explored the cutting-edge science behind new treatments and how it is transforming patients’ lives.
Read Article -
EFPIA News 25.06.18
Apply now for the Health Collaboration Awards 2018
Submit a project by 21 September 2018
Read Article -
EFPIA News 08.05.18
EFPIA position on proposal for a Regulation of the European Parliament and the Council on HTA and amending...
This paper outlines EFPIA’s views on the four pillars of EU HTA cooperation included in the Commission proposal
Read Article -
EFPIA News 03.05.18
Early Career Research Prize in Vaccinology R&D – 2nd edition
Promote and foster a younger generation of scientists in the early stages of their career!
Read Article -
EFPIA News 03.07.17
EFPIA-College of Europe Prize
The 2017 Laureat of the EFPIA-College of Europe Prize is Luca Deplano
Read Article
No results found for “”
No results found for filter “”
-
Statements & press releases 22.01.20
EFPIA statement on CJEU ruling on clinical trial transparency
EFPIA notes the decision by the Court of Justice of the European Union (CJEU) in the case of PTC Therapeutics International v EMA (C-175/18 P) and MSD...
Read Article -
Statements & press releases 06.12.19
Medicines shortages: root causes and potential solutions
Our associations are committed to stepping up efforts to prevent and to mitigate medicines shortages
Read Article -
Statements & press releases 03.12.19
New IMI project “COMBINE” launched to accelerate the fight against antimicrobial resistance
COMBINE will support the coordination of the Innovative Medicines Initiative (IMI) Antimicrobial Resistance (AMR) Accelerator Programme to progress a pipeline...
Read Article -
Statements & press releases 29.11.19
Commission Proposal for a European Regulation on HTA
Europe cannot afford an inefficient system for joint clinical assessments
Read Article -
Statements & press releases 26.11.19
European industries unite to call for an ambitious EU industrial strategy
Industry4Europe, a coalition of 149 sector Associations representing the diversity of the EU’s industrial base, today published its new Joint Paper ‘A...
Read Article -
Statements & press releases 18.11.19
Calling on the EU to remain on the front line of the global battle against AMR – industry stands ready...
As we embark on World Antibiotic Awareness Week and European Antibiotic Awareness Day, EFPIA, Vaccines Europe, and their Members reiterate their commitment...
Read Article -
Statements & press releases 12.11.19
A wake-up call for HTA bodies and payers on assessing and valuing person-centered therapeutic innovations...
Person-centered therapeutic innovations can have a significant and tangible impact on patients’ quality of life, improve adherence and as a consequence...
Read Article -
Statements & press releases 05.11.19
Everybody believes in partnership. But you need a strong vision to make it happen.
“Solutions from the past are not working for the challenges of the future”.
Read Article -
Statements & press releases 24.10.19
EFPIA position on clinical trial transparency
The biopharmaceutical industry believes that the disclosure of clinical trial results and appropriate sharing of clinical trial data is in the best interests...
Read Article -
Statements & press releases 24.10.19
The economy of well-being
EFPIA welcomes the Council Conclusions on the Economy of Wellbeing, aiming to put people and their wellbeing at the centre of policy-making
Read Article -
Statements & press releases 23.10.19
Have your say and contribute to the strategic research agenda for a Public-Private Partnership for Health...
The goal is to create a unique platform that does not exist anywhere else, a European multi-sector Partnership for health innovation
Read Article -
Statements & press releases 20.09.19
EFPIA statement on Medicine Shortages in Europe
Drug shortages are a growing source of concern and industry is taking every possible step in our capacity to minimise the impact of shortages for patients....
Read Article
No results found for “”
No results found for filter “”
-
Blog articles 24.01.20
Everyday counts: 9 reasons why patients wait longer to get access to new cancer medicines
Working together to jointly identify factors which cause access delays, and co-create solutions that could accelerate time to patient access
Read Article -
Blog articles 15.01.20
Cancer care in Europe: Where are we in 2020?
Creating more moments that matter: Cancer death rates are falling thanks to advances in prevention, diagnosis and treatment
Read Article -
Blog articles 15.01.20
Medicines shortages – from assumptions to evidence to action
Addressing the issue of shortages is a priority for the research-based industry in Europe as well as for supply chain stakeholders and national competent...
Read Article -
Blog articles 18.12.19
A European Cancer Plan – For better, more equal access to cancer care (Guest blog)
In a joint effort, ECCO, ECPC and EFPIA have recently put the European Cancer Plan on the agenda of a session of the European Health Forum Gastein.
Read Article -
Blog articles 12.12.19
Precision oncology: The right treatment to the right patient at the right time (Guest blog)
A new position paper highlights the value of personalised oncology treatments and biomarkers – and proposes concrete steps to accelerate their introduction....
Read Article -
Blog articles 04.12.19
Everyday counts: time to patient access to innovative oncology therapies in Europe
What factors delay access to new cancer medicines across Europe? Which best practices and what recommendations can improve time to patient access?
Read Article -
Blog articles 27.11.19
A European Health Data Space – a small step or a giant leap?
Voltaire once supposedly said of the Holy Roman Empire that it was neither especially Holy or Roman, nor an Empire.
Read Article -
Blog articles 21.11.19
Improving Outcomes for People with Diabetes: How Data, Access to Innovation and Rethinking Care Can Unleash...
Sharing solutions to a growing health crisis
Read Article -
Blog articles 20.11.19
Orphan drugs & paediatric medicines: how to deliver for children with rare diseases (Guest blog)
Incentives have increased the number of medicines for children with rare conditions – here’s how Europe can do even better
Read Article -
Blog articles 07.11.19
“If you always do what you’ve always done, you’ll always get what you’ve always got”
We need to work together to ensure access to treatments today and develop the medicines of the future.
Read Article -
Blog articles 06.11.19
In a world of finite resources, we cannot afford an inefficient use of health spending
Around 10% of EU GDP is spent on healthcare; yet, as much as one-fifth is spent inefficiently, making no meaningful contribution to health outcomes.
Read Article -
Blog articles 31.10.19
#WeWontRest until we beat Alzheimer’s disease – together
Unlocking the mystery behind Alzheimer's disease and dementia and improving care for people require new types of partnership. As we navigate uncertain...
Read Article